Catherine Mauvais Aung

Catherine Mauvais Aung is an accomplished executive with extensive experience in digital health transformation and innovation. Currently serving as Group General Manager for Digital Health Transformation and Business To Consumer at Mediclinic since 2022, Catherine also holds roles as a Member of the Cercle suisse des administratrices and as an Advisory Council Member for Harvard Business Review. Previous positions include Head of Digital Business at Evonik, Head of Global Innovation Lab at Ferring Pharmaceuticals, and various leadership roles at Nestle. Catherine's educational background includes ongoing studies in Digital Marketing at Yale School of Management and several executive programs from prestigious institutions such as MIT Sloan and Harvard Business School.